| Literature DB >> 33733048 |
Kelly E Wingerter1, Kimberly R O'Dell2, Annemarie J Anglim3, Alison L Bailey4.
Abstract
BACKGROUND: Acute myocardial infarction in pregnancy is occasionally due to spontaneous coronary artery dissection (SCAD). Although uncommon, the majority of cases of pregnancy-associated SCAD (pSCAD) has critical presentations with more profound defects that portend high maternal and foetal mortality, and frequently necessitate preterm delivery. This is a case of pSCAD with ongoing ischaemia that required temporary mechanical circulatory support (MCS) and emergent revascularization, while the pregnancy was successfully continued to early-term. CASEEntities:
Keywords: ACS; Cardio-obstetrics; Case report; Revascularization; SCAD; Shock
Year: 2021 PMID: 33733048 PMCID: PMC7948075 DOI: 10.1093/ehjcr/ytab080
Source DB: PubMed Journal: Eur Heart J Case Rep ISSN: 2514-2119
| Day 0 | Initial presentation and evaluation |
Main complaint: severe substernal, burning chest pain, and dyspnoea EKG: ST elevations in anterolateral leads Cardiac catheterization: proximal left anterior descending (LAD) dissection with intramural haematoma with thrombolysis in myocardial infarction 3 flow |
| Day 1 | Transfer to tertiary centre for maternal foetal medicine service and presentation to tertiary care centre |
EKG: persistent ST elevations in anterolateral leads Echocardiogram with ejection fraction (EF) <20% Development of cardiogenic shock |
| Day 1 | Intervention |
Placement of percutaneous left ventricular assist device (pLVAD) Revascularization with left internal mammary artery to LAD and saphenous vein graft to diagonal |
| Day 2–40 | Post-operative course: initial admission to cardiovascular intensive care unit (CVICU) and transferred to high-risk perinatal unit once stable |
pLVAD removed NSVT on telemetry Metoprolol tartrate initiated with dose adjusted throughout hospitalization Furosemide 20–40 mg IV as needed |
| Day 41–43 | Post-operative course: delivery |
Transfer to CVICU for haemodynamic monitoring during delivery Induction with oxytocin Forceps assisted passive second stage vaginal delivery Furosemide 40 mg IV administered to mitigate volume shifts Discharged home following day |
| Day 44–365 | Post-discharge follow-up |
Initiation of goal-directed medical therapy ECHO with unchanged EF AICD placed for primary prevention |